News

Filter

Current filters:

Serodus

Serodus to acquire Phlogo to expand cardiovascular portfolio

12-07-2013

Norwegian biopharma company Serodus (Oslo Axess: SER) says that, following approval by an extraordinary…

BiotechnologyCardio-vascularMergers & AcquisitionsPhlogoSER130SER140Serodus

Serodus buys rights to Roche drug for potential treatment of heart failure

14-12-2010

Norway’s Serodus has entered into a license agreement with Swiss drug major Roche (ROG: VX) for…

Cardio-vascularLicensingPharmaceuticalRocheSerodus

COMPANY SPOTLIGHT

Menarini

Back to top